These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 2836804
1. Reduced DNA topoisomerase II activity in ataxia-telangiectasia cells. Singh SP, Mohamed R, Salmond C, Lavin MF. Nucleic Acids Res; 1988 May 11; 16(9):3919-29. PubMed ID: 2836804 [Abstract] [Full Text] [Related]
2. A defect in DNA topoisomerase II activity in ataxia-telangiectasia cells. Mohamed R, Pal Singh S, Kumar S, Lavin MF. Biochem Biophys Res Commun; 1987 Nov 30; 149(1):233-8. PubMed ID: 2825700 [Abstract] [Full Text] [Related]
3. Defective DNA topoisomerase II in ataxia-telangiectasia cells. Lavin MF, Singh SP. Acta Biol Hung; 1990 Nov 30; 41(1-3):125-35. PubMed ID: 1965559 [Abstract] [Full Text] [Related]
4. Study of DNA topoisomerase II in ataxia-telangiectasia cells. Singh SP, Lavin MF. Carcinogenesis; 1989 Jul 30; 10(7):1215-8. PubMed ID: 2472231 [Abstract] [Full Text] [Related]
7. Overproduction of topoisomerase II in an ataxia telangiectasia fibroblast cell line: comparison with a topoisomerase II-overproducing hamster cell mutant. Davies SM, Harris AL, Hickson ID. Nucleic Acids Res; 1989 Feb 25; 17(4):1337-51. PubMed ID: 2537956 [Abstract] [Full Text] [Related]
8. Association of topoisomerases I and II with the chromatin in SV40-infected monkey cells. Rainwater R, Mann K. Virology; 1991 Mar 25; 181(1):408-11. PubMed ID: 1847264 [Abstract] [Full Text] [Related]
9. Quantitative adaptation of the bacteriophage P4 DNA unknotting assay for use in the biochemical and pharmacological characterization of topoisomerase II. Hofmann GA, Mirabelli CK, Drake FH. Anticancer Drug Des; 1990 Aug 25; 5(3):273-82. PubMed ID: 2169250 [Abstract] [Full Text] [Related]
10. Apurinic and/or apyrimidinic endonuclease activity in ataxia telangiectasia cell extracts. Sheridan RB, Huang PC. Mutat Res; 1978 Oct 25; 52(1):129-36. PubMed ID: 215905 [Abstract] [Full Text] [Related]
12. DNA topoisomerases I and II in human mature sperm cells: characterization and unique properties. Har-Vardi I, Mali R, Breietman M, Sonin Y, Albotiano S, Levitas E, Potashnik G, Priel E. Hum Reprod; 2007 Aug 25; 22(8):2183-9. PubMed ID: 17656417 [Abstract] [Full Text] [Related]
14. The purification and characterization of DNA topoisomerases I and II of the yeast Saccharomyces cerevisiae. Goto T, Laipis P, Wang JC. J Biol Chem; 1984 Aug 25; 259(16):10422-9. PubMed ID: 6088500 [Abstract] [Full Text] [Related]
15. DNA topoisomerase II-dependent cytotoxicity of alkylaminoanthraquinones and their N-oxides. Smith PJ, Blunt NJ, Desnoyers R, Giles Y, Patterson LH. Cancer Chemother Pharmacol; 1997 Aug 25; 39(5):455-61. PubMed ID: 9054961 [Abstract] [Full Text] [Related]
16. Topoisomerase II, not topoisomerase I, is the proficient relaxase of nucleosomal DNA. Salceda J, Fernández X, Roca J. EMBO J; 2006 Jun 07; 25(11):2575-83. PubMed ID: 16710299 [Abstract] [Full Text] [Related]
17. Active DNA topoisomerase II with minimum molecular mass from regenerating rat liver. Park SH, Lee CG, Namkung R, Kim CG, Park SD. Biochem Mol Biol Int; 1994 Mar 07; 32(4):641-50. PubMed ID: 8038715 [Abstract] [Full Text] [Related]
18. Aberrant DNA topoisomerase II activity, radioresistance and inherited susceptibility to cancer. Cunningham JM, Francis GE, Holland MJ, Pirollo KF, Chang EH. Br J Cancer; 1991 Jan 07; 63(1):29-36. PubMed ID: 1846552 [Abstract] [Full Text] [Related]